πŸ‡ΊπŸ‡Έ FDA
Patent

US 7795428

Dipeptidyl peptidase inhibitors

granted A61PA61P13/08A61P13/12

Quick answer

US patent 7795428 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
59
CPC classes
A61P, A61P13/08, A61P13/12, A61P15/08, A61P15/16